Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients

Devayani Machiraju; Melanie Wiecken; Nina Lang; Ingrid Hülsmeyer; Jasmin Roth; Timo E. Schank; R Eurich; Niels Halama; Alexander Enk; Jessica C. Hassel

doi:10.1080/2162402x.2021.1926762

Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients

Authors: Devayani Machiraju, Melanie Wiecken, Nina Lang, Ingrid Hülsmeyer, Jasmin Roth, Timo E. Schank, R Eurich, Niels Halama, Alexander Enk, Jessica C. Hassel - OncoImmunology 2021 cited by 62

= .07). Different soluble immune checkpoints characterized checkpoint inhibitor-resistant melanoma. Measuring these serum markers may have the potential to be used in clinical routine.